← Editorial teamCoverage area
Outcomes writer
This GLP articles covering Weight regain after discontinuation, Tolerability over the first six months, Plateaus and dose escalation decisions, Maintenance dosing and long-term cost, What continuation actually requires of a patient, Trial follow-up beyond the primary endpoint.
Published by This GLP Editorial Team. This collection brings together sourced articles on what the months actually look like — the plateau, the side effects, stopping. These pages explain available evidence; they do not provide a clinical opinion or claim firsthand treatment experience.
Coverage
- Weight regain after discontinuation
- Tolerability over the first six months
- Plateaus and dose escalation decisions
- Maintenance dosing and long-term cost
- What continuation actually requires of a patient
- Trial follow-up beyond the primary endpoint
Articles in this collection
70 pieces- Can You Take Metformin and Ozempic Together? Most Trials Required ItSafety
- Does Ozempic Cause Constipation? What the Trials Counted, and When It EasesSafety
- Why Does Ozempic Cause Sulfur Burps? What the Adverse-Event Data ShowSafety
- Can Tirzepatide Cause Anxiety or Depression? Trials Say No, Records Are MixedSafety
- Does Zepbound Cause Headaches? Headache Never Made Its Side-Effect TableSafety
- Does Semaglutide Help Type 1 Diabetes? What Two Small Trials FoundEvidence
- Do GLP-1 Drugs Work After Bariatric Surgery? Two Randomized Trials Say YesEvidence
- What Happens When You Stop Tirzepatide? SURMOUNT-4 Says 14% Comes BackEvidence
- Does Ozempic Cause Hair Loss? What 1,091,743 Records ShowSafety
- Do GLP-1 Drugs Improve Your Quality of Life? 2.12 Points on the SF-36Evidence
- Do GLP-1 Drugs Cause Blood Clots? No Untreated Group Was Ever FollowedEvidence
- Do GLP-1 Drugs Work the Same in Asian Patients? The Percentages MatchEvidence
- Do GLP-1 Drugs Help IBS? Coded Symptoms Fell by Two to Four PointsEvidence
- Do GLP-1 Drugs Help Bipolar Disorder? One Drug Moved, Two Did NotEvidence
- Tirzepatide and Serum Uric Acid: A SURMOUNT-1 Post Hoc AnalysisEvidence
- Tirzepatide in HFpEF by Sex: SUMMIT Trial Results in Women and MenEvidence
- Can You Take a GLP-1 With a Heart Pump? 141 Pairs, and No Effect SizesEvidence
- Do GLP-1 Drugs Help Intracranial Hypertension? Probably, but Less Than ReportedEvidence
- Are GLP-1 Drugs Safe for Older Adults? Seven Trials, and Who They Left OutSafety
- How Much Less Do You Eat on a GLP-1? About 271 Calories at One MealEvidence
- Can You Take a GLP-1 With Sickle Cell Disease? One Cohort, 1,391 PairsEvidence
- Survodutide in MASH: How Much of the Liver Benefit Was Weight LossEvidence
- Do GLP-1 Drugs Help Rheumatoid Arthritis? The Heart Result, Not the JointsEvidence
- Alcohol Admissions After Stopping a GLP-1: Swedish Within-Person DataEvidence
- Do GLP-1 Drugs Reduce Inflammation? hsCRP Fell 37.8% in SELECTEvidence
- Do GLP-1 Drugs Help Crohn's Disease? Hospitalization Halved, Steroids UnchangedEvidence
- Asthma Exacerbations on GLP-1 Drugs vs Other Weight MedicationsEvidence
- Do GLP-1 Drugs Make You Tired? Daytime Sleepiness Improved by 0.20 PointsSafety
- Bone Mineral Density on GLP-1 Drugs in Type 2 Diabetes: 25 TrialsEvidence
- Do GLP-1 Drugs Help Atrial Fibrillation? The Evidence Disagrees With ItselfEvidence
- Why Isn't Obesity in Your Medical Record? One in Ten Had It Written DownEvidence
- Bariatric Surgery vs GLP-1 Drugs on Cardiovascular EventsEvidence
- GLP-1 Storefronts Sharing One Application Build, Matched by HashFormats
- Do GLP-1 Drugs Cause Gastroparesis? Thirteen Cases, and Two Opposite FindingsSafety
- Unexpected Pregnancy on a GLP-1: Why Weight Loss Makes It LikelierSafety
- Semaglutide and Suicidal Ideation: The Large Matched Cohort StudiesSafety
- Do GLP-1 Drugs Change Your Sense of Taste? Scores Fell From 40.63 to 28.61Evidence
- Do GLP-1 Drugs Cause Thyroid Cancer? A Bound, Not a VerdictSafety
- Does a GLP-1 Affect Surgery Outcomes? Four Procedures, Four Different AnswersEvidence
- Do GLP-1 Drugs Prevent Diabetic Foot Ulcers? The Database Cannot SayEvidence
- GLP-1 Dosing Errors in FDA Adverse Event ReportsSafety
- Are GLP-1 Drugs Bad for Your Liver? The Evidence Says BetterEvidence
- High-Dose vs Standard-Dose GLP-1 Before Neck Fusion (ACDF) SurgeryEvidence
- Exenatide for Smoking Cessation: Five Subgroups From One Pilot TrialEvidence
- Do GLP-1 Drugs Cause Gout? The Study Everyone Cites Cannot SayEvidence
- GLP-1 Weight Loss Across 32 Trials: The 9.36% Average and Its SpreadEvidence
- GLP-1 Price Freshness: How Old Published Seller Prices AreFormats
- GLP-1 Seller Disclosures: Does Publishing One Predict Another?Formats
- Do GLP-1 Drugs Raise Testosterone? Not in the Trials That Measured ItEvidence
- Oral Semaglutide vs DPP-4 Inhibitors and Cognitive Impairment in HFpEFEvidence
- What New Weight Loss Drugs Are Coming? Retatrutide Leads at 22.1%Evidence
- Do GLP-1 Drugs Protect Against Dementia? A Predictor MovedEvidence
- Do GLP-1 Drugs Slow Aging? Three Clocks Moved, One Mouse Lifespan DidEvidence
- Does Semaglutide Make Diabetic Retinopathy Worse? In One Trial, YesSafety
- Why Does Weight Loss Plateau on a GLP-1? The Drug Is Still WorkingEvidence
- Do GLP-1 Drugs Help Hidradenitis Suppurativa? Twenty People, No Control GroupEvidence
- Can You Take a GLP-1 With Polycystic Kidney Disease? Not as a TreatmentEvidence
- Semaglutide Lifespan Study in Female Mice: 742 vs 834 DaysEvidence
- Semaglutide Carbon Footprint: A UK Lifetime Emissions ModelEvidence
- Semaglutide for MASH in Japanese Patients: The ESSENCE SubgroupEvidence
- Semaglutide Psychiatric Risk Meta-Analysis: Trials Pooled With Report CountsSafety
- Semaglutide vs Sleeve Gastrectomy: Liver Stiffness Over 72 WeeksEvidence
- Telehealth Semaglutide and Tirzepatide Program: 12.3% at 24 WeeksEvidence
- Semaglutide vs Liraglutide After Bariatric Surgery: Weight and Lean MassEvidence
- Are GLP-1 Drugs Safe for Teens? The Trials, and What Is Outside ThemEvidence
- Do GLP-1 Drugs Work in Menopause? The Subgroup Nobody ReportedSafety
- Oral Semaglutide 25 mg: OASIS 4 Trial Results at 71 WeeksFormats
- Does Semaglutide Cause Vision Loss? The Signal Sits in DiabetesSafety
- GLP-1 Withdrawal Trials: STEP 1, STEP 4 and SURMOUNT-4 ComparedEvidence
- How Long Does Nausea Last on a GLP-1? Through the EscalationEvidence